{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:49:59Z","timestamp":1774342199533,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,3,30]],"date-time":"2004-03-30T00:00:00Z","timestamp":1080604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endogenous or exogenous \u03b2\u2010carboline (\u03b2C) derivatives structurally related to the selective dopaminergic neurotoxin 1\u2010methyl\u20104\u2010phenyl\u20101,2,3,6\u2010tetrahydropyridine (MPTP) and its active metabolite 1\u2010methyl\u20104\u2010phenylpyridinium (MPP<jats:sup>+<\/jats:sup>) may contribute to dopaminergic neurodegeneration in Parkinson's disease (PD). We addressed the importance of the dopamine transporter (DAT) for selective dopaminergic toxicity by testing the differential cytotoxicity and cellular uptake of 12 \u03b2Cs in human embryonic kidney HEK\u2010293 cells ectopically expressing the DAT gene. Cell death was measured using [4,5\u2010Dimethylthiazol\u20102\u2010yl]\u20102,5\u2010diphenyltetrazolium bromide (MTT) and trypan blue exclusion assays, and uptake by a fluorescence\u2010based uptake assay. All \u03b2Cs and MPP<jats:sup>+<\/jats:sup> showed general cytotoxicity in parental HEK\u2010293 cells after 72\u2003h with half\u2010maximal toxic concentrations (TC<jats:sub>50<\/jats:sub> values) in the upper micromolar range. Besides MPP<jats:sup>+<\/jats:sup>, only 2[<jats:italic>N<\/jats:italic>]\u2010methylated compounds showed enhanced cytotoxicity in DAT expressing HEK\u2010293 cells with 1.3\u2010 to 4.5\u2010fold reduction of TC<jats:sub>50<\/jats:sub> values compared with parental cell line. The rank order of selectivity was: MPP<jats:sup>+<\/jats:sup>\u2003&gt;&gt;\u20032[<jats:italic>N<\/jats:italic>],9[<jats:italic>N<\/jats:italic>]\u2010dimethyl\u2010harminium &gt; 2[<jats:italic>N<\/jats:italic>]\u2010methyl\u2010harminium\u2003&gt;\u20032[<jats:italic>N<\/jats:italic>],9[<jats:italic>N<\/jats:italic>]\u2010dimethyl\u2010harmanium\u2003=\u20032[<jats:italic>N<\/jats:italic>]\u2010methyl\u2010norharmanium &gt; 2[<jats:italic>N<\/jats:italic>]\u2010methyl\u2010harmanium &gt; 2[<jats:italic>N<\/jats:italic>],9[<jats:italic>N<\/jats:italic>]\u2010dimethyl\u2010norharminium. Consistently, only 2[<jats:italic>N<\/jats:italic>]\u2010methylated \u03b2Cs were transported into the cell through the DAT with up to five times greater <jats:italic>K<\/jats:italic><jats:sub>m<\/jats:sub> and 12\u2013220 times smaller <jats:italic>V<\/jats:italic><jats:sub>max<\/jats:sub> values compared with dopamine and MPP<jats:sup>+<\/jats:sup>. There was a weak relation of DAT\u2010mediated selectivity with the affinity of \u03b2Cs at the DAT (<jats:italic>K<\/jats:italic><jats:sub>m<\/jats:sub>), but not with <jats:italic>V<\/jats:italic><jats:sub>max<\/jats:sub>. Our data suggest that DAT\u2010mediated cellular uptake of 2[<jats:italic>N<\/jats:italic>]\u2010methylated \u03b2Cs represents a potential mechanism for selective toxicity towards dopaminergic neurons and may be relevant for the pathogenesis of Parkinson's disease.<\/jats:p>","DOI":"10.1111\/j.1471-4159.2004.02397.x","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T16:49:37Z","timestamp":1133455777000},"page":"685-694","source":"Crossref","is-referenced-by-count":42,"title":["Dopamine transporter\u2010mediated cytotoxicity of \u03b2\u2010carbolinium derivatives related to Parkinson's disease: relationship to transporter\u2010dependent uptake"],"prefix":"10.1111","volume":"89","author":[{"given":"Alexander","family":"Storch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2010I","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra A.","family":"Gearhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Warren","family":"Beach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Neafsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,3,30]]},"reference":[{"key":"e_1_2_17_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.23.9368"},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)96446-5"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12584"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(93)90187-T"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02816115"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02815143"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.62041503.x"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(85)90016-3"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1269-1_13"},{"key":"e_1_2_17_11_1","first-page":"179","article-title":"Endogenous analogs of MPTP: indolamine\u2010derived tetrahydro\u2010\u03b2\u2010carbolines as potential causative factors in Parkinson's diseases","volume":"45","author":"Collins M. A.","year":"1986","journal-title":"Adv. Neurol."},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)90576-U"},{"key":"e_1_2_17_13_1","first-page":"1259","article-title":"Inhibitors of NO synthase and poly(ADP\u2010ribose) synthase (PARS) do not block toxic actions of \u03b2\u2010carbolinium cations or MPP+ in mesencephalic cultures","volume":"21","author":"Collins M. A.","year":"1995","journal-title":"Abstr. Soc. Neurosci."},{"key":"e_1_2_17_14_1","first-page":"171","article-title":"\u03b2\u2010Carbolines: metabolism and neurotoxicity","volume":"12","author":"Collins M. A.","year":"1996","journal-title":"Biogen. Amines"},{"key":"e_1_2_17_15_1","first-page":"65","article-title":"Comparative analysis of three methods to assess viability of mammalian cells in culture","volume":"23","author":"Da Costa A. O.","year":"1999","journal-title":"Biocell"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(86)90368-6"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90318-6"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(92)90722-9"},{"key":"e_1_2_17_19_1","first-page":"269","volume-title":"N\u2010Methylation of \u03b2\u2010carbolines as a potential bioactivation route in Parkinson's disease.","author":"Gearhart D. A.","year":"1997"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1027351120616"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.2000.0287"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0186(01)00115-2"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(99)01313-8"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19971117)388:2<211::AID-CNE3>3.0.CO;2-4"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600620105"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(87)90931-4"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1974.tb09361.x"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4889(98)00071-8"},{"key":"e_1_2_17_29_1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj2910673","article-title":"Is complex II involved in the inhibition of mitochondrial respiration by N\u2010methyl\u20104\u2010phenylpyridinium cation (MMP+) and N\u2010methyl\u2010beta\u2010carbolines?","volume":"291","author":"Krueger M. J.","year":"1993","journal-title":"Biochem. J."},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810153391607"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810083391506"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120523"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb09400.x"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.12.2240"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.70020727.x"},{"key":"e_1_2_17_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00131-9"},{"key":"e_1_2_17_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.62030998.x"},{"key":"e_1_2_17_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200004)47:4<528::AID-ANA20>3.0.CO;2-R"},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10187"},{"key":"e_1_2_17_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.1.30"},{"key":"e_1_2_17_41_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.13-10-04246.1993"},{"key":"e_1_2_17_42_1","first-page":"1437","article-title":"Catecholamine transporters and 1\u2010methyl\u20104\u2010phenyl\u20101,2,3,6\u2010tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter","volume":"277","author":"Pifl C.","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1269-1_3"},{"key":"e_1_2_17_44_1","doi-asserted-by":"crossref","unstructured":"SpenserI. D.(1956)The structure ofN\u2010alkyl\u2010\u03b2\u2010carboline anhydro\u2010bases.J. Chem. Soc.3659\u20133663.","DOI":"10.1039\/JR9560003659"},{"key":"e_1_2_17_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1269-1_2"},{"key":"e_1_2_17_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0186(99)00083-2"},{"key":"e_1_2_17_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(01)00922-4"},{"key":"e_1_2_17_48_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408447909037483"},{"key":"e_1_2_17_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(97)00050-X"},{"key":"e_1_2_17_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90538-2"},{"key":"e_1_2_17_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(88)90249-7"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2004.02397.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2004.02397.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T05:46:49Z","timestamp":1697348809000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2004.02397.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,30]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.1471-4159.2004.02397.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02397.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,30]]}}}